Immunovant, Inc. (IMVT) Reports In-Line Q2 EPS

Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.45), in-line with the analyst estimate of ($0.45).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
• AutoZone beats profit view but misses on revenue